Actively Recruiting
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Led by Kuopio University Hospital · Updated on 2025-09-03
200
Participants Needed
1
Research Sites
501 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
CONDITIONS
Official Title
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mild Cognitive Impairment due to Alzheimer's disease
- Dementia with Lewy Bodies
- Frontotemporal dementia
- Idiopathic normal pressure hydrocephalus (iNPH)
- Age 18 years or older
You will not qualify if you...
- History of seizures
- Pregnancy
- Metal implants in the head (except dental fillings)
- Electronic implants such as pacemaker or implanted medical pump
- Age below 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kuopio University Hospital
Kuopio, Finland
Actively Recruiting
Research Team
E
Eino Solje, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here